Arrowhead Pharmaceuticals, Inc.
$74.93
$1.46(-1.91%)
Arrowhead Pharmaceuticals, Inc.
ARWR
$74.93
$1.46(-1.91%)
Arrowhead Pharmaceuticals, Inc.
ARWR
NASDAQ
$74.93
$1.46(-1.91%)
Chart
Upcoming Earnings
Next report date
May 7, 2026
Report period
Q2 2026
EPS Estimate
$-1.11
Revenue Estimate
$73.84M
Key stats
52-Week Range$74.93
$12.44
$77.89
Market capitalization
$10.49BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
51.80Basic EPS (TTM)
$1.57Net income (TTM)
$202.27MRevenue (TTM)
$1.09BAvg. volume
2.60MBeta (1Y)
1.27Employees
609Market capitalization
$10.49BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
51.80Basic EPS (TTM)
$1.57Net income (TTM)
$202.27MRevenue (TTM)
$1.09BAvg. volume
2.60MBeta (1Y)
1.27Employees
609Screener Quick Check
Sign in to check this stock against your screeners
Sign InAbout Arrowhead Pharmaceuticals, Inc.
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher R. Anzalone
Website
arrowheadpharma.comHeadquarters
177 East Colorado Boulevard, Pasadena, CA, 91105
IPO Date
1993-12-16
Identifiers
ISIN
US04280A1007Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The...
Related Stocks
$223.06
1D:
-0.3%
1Y:
91.5%
US05464T1043Healthcare
Mkt Cap
$11.41B
P/E Ratio TTM
-57.1
Revenue TTM
$638.50M
Beta
0.47
Earnings TTM
$-183.17M
Dividend Yield TTM
0.00%
$284.57
1D:
-0.8%
1Y:
75.3%
US5011471027Healthcare
Mkt Cap
$8.38B
P/E Ratio TTM
37.6
Revenue TTM
$389.13M
Beta
0.54
Earnings TTM
$204.83M
Dividend Yield TTM
0.00%
Dividend Overview
This company does not pay dividends
Financials
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q2 '26
Actual
Estimate
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q2 '26
Actual
Estimate